Detalhe da pesquisa
1.
Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection.
J Virol
; 98(6): e0027324, 2024 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38775481
2.
Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.
PLoS Pathog
; 18(3): e1010396, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35358290
3.
CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab.
Front Immunol
; 12: 794638, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34868084
4.
Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission.
Nat Commun
; 12(1): 3343, 2021 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34099693